Related Experiment Videos
Herpes simplex virus vaccines as immunotherapeutic agents
1Divn of Infectious Diseases, Children's Hospital Research Foundation, University of Cincinnati College of Medicine, OH 45229-3039, USA.
Trends in Microbiology
|June 1, 1995
Summary
Persistent viruses cause chronic disease by evading immune surveillance. Recent research demonstrates that vaccine immunotherapy effectively treats persistent viral infections, using herpes simplex virus as a model.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Persistent viruses pose significant challenges due to their ability to evade immune surveillance.
- Chronic or recurrent diseases resulting from persistent viral infections are a major public health concern.
Purpose of the Study:
- To establish the efficacy of vaccine immunotherapy in treating persistent viral infections.
- To utilize herpes simplex virus infection as a model for persistent viral disease research.
Main Methods:
- The study involved nearly 60 years of research culminating in recent reproducible data.
- Herpes simplex virus infection was employed as a model system.
Main Results:
- Reproducible data confirmed the effectiveness of vaccine immunotherapy.
- Vaccine immunotherapy demonstrated significant therapeutic potential against persistent viral infections.
Conclusions:
- Vaccine immunotherapy is an effective treatment strategy for persistent viral infections.
- This breakthrough offers new hope for managing chronic viral diseases.